Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.

OBJECTIVE: To compare the use of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis (kala-azar). METHODS: A total of 102 patients with confirmed kala-azar were treated in a mission hospital in West Pokot region, Kenya, with sodium stibogluconate (20 mg/kg/day f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Moore, E., O'Flaherty, D., Heuvelmans, H., Seaman, J., Veeken, H., de Wit, S., Davidson, R. N.
Formato: Artigo
Idioma:Inglês
Publicado: World Health Organization 2001
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2566419/
https://ncbi.nlm.nih.gov/pubmed/11417033
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares